Arno van Cruchten

1.2k total citations
16 papers, 894 citations indexed

About

Arno van Cruchten is a scholar working on Molecular Biology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Arno van Cruchten has authored 16 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Arno van Cruchten's work include Metabolism and Genetic Disorders (10 papers), Biochemical and Molecular Research (8 papers) and Neonatal Health and Biochemistry (6 papers). Arno van Cruchten is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Biochemical and Molecular Research (8 papers) and Neonatal Health and Biochemistry (6 papers). Arno van Cruchten collaborates with scholars based in Netherlands, South Africa and Japan. Arno van Cruchten's co-authors include Ronald J. A. Wanders, Lodewijk IJlst, Carlo W.T. van Roermund, André B. P. Kuilenburg, Albert H. Gennip, Hans R. Waterham, Wouter F. Visser, Wim Kulik, Albert H. Bootsma and Tetsuya Ito and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and The FASEB Journal.

In The Last Decade

Arno van Cruchten

16 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arno van Cruchten Netherlands 14 646 297 173 162 107 16 894
Tamara Ramadan Switzerland 10 361 0.6× 132 0.4× 101 0.6× 57 0.4× 285 2.7× 11 832
Pilar Rodríguez‐Pombo Spain 22 870 1.3× 730 2.5× 131 0.8× 78 0.5× 156 1.5× 57 1.3k
Anne‐Marie Lamhonwah Canada 18 428 0.7× 381 1.3× 118 0.7× 68 0.4× 117 1.1× 25 771
Mohammed Almannai Saudi Arabia 17 597 0.9× 381 1.3× 125 0.7× 81 0.5× 40 0.4× 43 935
Joy Yaplito‐Lee Australia 17 653 1.0× 575 1.9× 193 1.1× 164 1.0× 78 0.7× 29 1.1k
Philip P. Dembure United States 16 403 0.6× 606 2.0× 200 1.2× 304 1.9× 256 2.4× 26 1.0k
V. Barash Israel 22 483 0.7× 229 0.8× 239 1.4× 163 1.0× 98 0.9× 49 1.1k
A. A. M. Morris United Kingdom 17 613 0.9× 529 1.8× 254 1.5× 115 0.7× 52 0.5× 27 1.0k
Claudia Carducci Italy 21 551 0.9× 732 2.5× 350 2.0× 111 0.7× 138 1.3× 69 1.2k
Jennifer R. Toone Canada 17 600 0.9× 627 2.1× 314 1.8× 157 1.0× 306 2.9× 39 1.2k

Countries citing papers authored by Arno van Cruchten

Since Specialization
Citations

This map shows the geographic impact of Arno van Cruchten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno van Cruchten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno van Cruchten more than expected).

Fields of papers citing papers by Arno van Cruchten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arno van Cruchten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno van Cruchten. The network helps show where Arno van Cruchten may publish in the future.

Co-authorship network of co-authors of Arno van Cruchten

This figure shows the co-authorship network connecting the top 25 collaborators of Arno van Cruchten. A scholar is included among the top collaborators of Arno van Cruchten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arno van Cruchten. Arno van Cruchten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gao, Arwen W., Iliana A. Chatzispyrou, Rashmi Kamble, et al.. (2017). A sensitive mass spectrometry platform identifies metabolic changes of life history traits in C. elegans. Scientific Reports. 7(1). 2408–2408. 55 indexed citations
2.
Durán, Marinus, Lodewijk IJlst, Wim Kulik, et al.. (2016). A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue. Molecular Genetics and Metabolism. 119(4). 307–310. 2 indexed citations
3.
Mason, Shayne, Carolus J. Reinecke, Willem Kulik, et al.. (2016). Cerebrospinal fluid in tuberculous meningitis exhibits only the L-enantiomer of lactic acid. BMC Infectious Diseases. 16(1). 251–251. 24 indexed citations
4.
IJlst, Lodewijk, M. Durán, Lodewyk J. Mienie, et al.. (2013). Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(12). 2510–2516. 29 indexed citations
5.
Aires, C. C. P., Arno van Cruchten, Lodewijk IJlst, et al.. (2010). New insights on the mechanisms of valproate-induced hyperammonemia: Inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. Journal of Hepatology. 55(2). 426–434. 94 indexed citations
6.
Ofman, Rob, Inge M. E. Dijkstra, Carlo W.T. van Roermund, et al.. (2010). The role of ELOVL1 in very long‐chain fatty acid homeostasis and X‐linked adrenoleukodystrophy. EMBO Molecular Medicine. 2(3). 90–97. 129 indexed citations
7.
Afink, Gijs, Willem Kulik, Henk Overmars, et al.. (2008). Molecular Characterization of Iodotyrosine Dehalogenase Deficiency in Patients with Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. 93(12). 4894–4901. 51 indexed citations
8.
Roermund, Carlo W.T. van, Wouter F. Visser, Lodewijk IJlst, et al.. (2008). The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters. The FASEB Journal. 22(12). 4201–4208. 181 indexed citations
9.
Kuilenburg, André B. P., Rutger Meinsma, Birgit Assmann, et al.. (2004). β-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. Human Molecular Genetics. 13(22). 2793–2801. 60 indexed citations
10.
Kuilenburg, André B. P., Henk van Lenthe, Arno van Cruchten, & Willem Kulik. (2004). Quantification of 5,6-Dihydrouracil by HPLC–Electrospray Tandem Mass Spectrometry. Clinical Chemistry. 50(1). 236–238. 21 indexed citations
11.
Lenthe, Henk van, André B. P. Kuilenburg, Tetsuya Ito, et al.. (2000). Defects in Pyrimidine Degradation Identified by HPLC-Electrospray Tandem Mass Spectrometry of Urine Specimens or Urine-soaked Filter Paper Strips. Clinical Chemistry. 46(12). 1916–1922. 48 indexed citations
12.
Ito, Tetsuya, André B. P. Kuilenburg, Albert H. Bootsma, et al.. (2000). Rapid Screening of High-Risk Patients for Disorders of Purine and Pyrimidine Metabolism Using HPLC-Electrospray Tandem Mass Spectrometry of Liquid Urine or Urine-soaked Filter Paper Strips. Clinical Chemistry. 46(4). 445–452. 89 indexed citations
13.
Ito, Tetsufumi, André B. P. Kuilenburg, Albert H. Bootsma, et al.. (2000). The application of HPLC/ESI tandem mass spectrometry on urine‐soaked filter‐paper strips for the screening of disorders of purine and pyrimidine metabolism. Journal of Inherited Metabolic Disease. 23(4). 434–437. 8 indexed citations
14.
Abeling, N.G.G.M., et al.. (1998). Aromatic L‐amino acid decarboxylase deficiency: A new case with a mild clinical presentation and unexpected laboratory findings. Journal of Inherited Metabolic Disease. 21(3). 240–242. 29 indexed citations
15.
Gennip, A. H. van, et al.. (1993). Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clinical Chemistry. 39(3). 380–385. 51 indexed citations
16.
Gennip, Albert H., et al.. (1989). Comparative Study of Thymine and Uracil Metabolism in Healthy Persons and in a Patient with Dihydropyrimidine Dehydrogenase Deficiency. Advances in experimental medicine and biology. 253A. 111–118. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamara Ramadan Breakdown of academic impact, for papers by Pilar Rodríguez‐Pombo Breakdown of academic impact, for papers by Anne‐Marie Lamhonwah Breakdown of academic impact, for papers by Mohammed Almannai Breakdown of academic impact, for papers by Joy Yaplito‐Lee Breakdown of academic impact, for papers by Philip P. Dembure Breakdown of academic impact, for papers by V. Barash Breakdown of academic impact, for papers by A. A. M. Morris Breakdown of academic impact, for papers by Claudia Carducci Breakdown of academic impact, for papers by Jennifer R. Toone
Rankless by CCL
2026